Home
News
Interviews
Companies
Videos
Markets
Subscribe
Recent News
Filter by Category
News
Spotlight
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filter by Company
Psilotec Health Solutions
w
Silo Wellness
w
Filament
w
Levitee Labs
w
Bionomics
w
Mindset Pharma
w
Psyence Group
w
CB Therapeutics
w
Small Pharma
w
Bexson Biomedical
w
Diamond Therapeutics
w
PsyBio Therapeutics
w
Nova Mentis Life Science
w
Psyched Wellness
w
Pharmather
w
Optimi Health
w
Mind Cure Health
w
Lophora
w
Thoughtful Brands Inc.
w
Unlimited Sciences
w
Doseology Sciences
w
Magical Brands
w
Tryp Therapeutics
w
MagicMed Industries
w
Core One Labs Inc.
w
Novamind Inc.
w
GoodCap Wellness
w
Pharmadrug Inc.
w
EGF Theramed Health Corp
w
Revive Therapeutics
w
Beckley Psytech
w
Awakn Life Sciences
w
TheraPsil
w
Lobe Sciences
w
Havn Life
w
Pure Extracts Corp
w
Red Light Holland
w
Orthogonal Thinker
w
MAPS
w
Mydecine Innovations Group
w
NeonMind Biosciences Inc.
w
Better Plant Sciences
w
Molecular Science Corp.
w
Wake Network
w
Gilgamesh Pharmaceuticals
w
Eleusis
w
Entheon Biomedical
w
Octarine Bio
w
Psygen Labs
w
EI.ventures
w
Compass Pathways
w
ATAI Life Sciences
w
Mind Medicine (MindMed)
w
Field Trip Health
w
Cybin Corp
w
Champignon Brands
w
Numinus
w
News
Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board
March 3, 2021
Lobe Sciences
News
MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research
March 3, 2021
Mind Cure Health
News
Novamind Expands Leadership Team, Accelerating M&A
March 3, 2021
Novamind Inc.
News
Nova Mentis Launches Autism Microbiome Study in the United States
March 3, 2021
Nova Mentis Life Science
News
Red Light Holland's iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert
March 3, 2021
Red Light Holland
News
Atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round
March 3, 2021
ATAI Life Sciences
News
Pure Extracts Submits Dealer’s Licence Application to Health Canada
March 3, 2021
Pure Extracts Corp
News
NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data
March 2, 2021
NeonMind Biosciences Inc.
News
Psyched Wellness Provides Update on Pre-Clinical Trial of its Muscimol Extract AME-1
March 2, 2021
Psyched Wellness
News
Mind Cure Completes Its Initial Strategic Equity Investment in ATMA, Canada's First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
March 2, 2021
Mind Cure Health
News
Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update
March 2, 2021
Numinus
News
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease
March 2, 2021
Pharmather
News
PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization
March 2, 2021
PsyBio Therapeutics
News
Optimi Health and Numinus Wellness to Conduct Psychedelic Lab Research and Development
March 2, 2021
Optimi Health
Numinus
News
Red Light Holland Launches New Logo and Interactive Wisdom Truffle Companion Created by Internationally Renowned & Award-Winning Designer Karim Rashid
March 2, 2021
Red Light Holland
News
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain
March 1, 2021
Mydecine Innovations Group
Previous
Next